- Previous Close
9.46 - Open
10.29 - Bid 11.06 x 100
- Ask 11.12 x 100
- Day's Range
10.29 - 11.65 - 52 Week Range
4.68 - 13.33 - Volume
937,866 - Avg. Volume
188,968 - Market Cap (intraday)
263.044M - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
-- - EPS (TTM)
-3.97 - Earnings Date Nov 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.00
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
www.inogen.comRecent News: INGN
View More
Performance Overview: INGN
Trailing total returns as of 11/8/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INGN
View MoreValuation Measures
Market Cap
263.04M
Enterprise Value
166.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.79
Price/Book (mrq)
1.40
Enterprise Value/Revenue
0.51
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.89%
Return on Assets (ttm)
-9.13%
Return on Equity (ttm)
-25.33%
Revenue (ttm)
331.52M
Net Income Avi to Common (ttm)
-52.69M
Diluted EPS (ttm)
-3.97
Balance Sheet and Cash Flow
Total Cash (mrq)
120.66M
Total Debt/Equity (mrq)
10.87%
Levered Free Cash Flow (ttm)
4.27M
Research Analysis: INGN
View MoreCompany Insights: INGN
INGN does not have Company Insights
Research Reports: INGN
View MoreLowering target price to $8.00
INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetRaising target price to $9.00
INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetLowering target price to $8.00
INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetWhat does Argus have to say about INGN?
INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target